• No results found

University of Groningen Biodegradable versus titanium osteosynthesis in maxillofacial traumatology Gareb, B; van Bakelen, N B; Dijkstra, P U; Vissink, A; Bos, R R M; van Minnen, B

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Biodegradable versus titanium osteosynthesis in maxillofacial traumatology Gareb, B; van Bakelen, N B; Dijkstra, P U; Vissink, A; Bos, R R M; van Minnen, B"

Copied!
12
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Biodegradable versus titanium osteosynthesis in maxillofacial traumatology

Gareb, B; van Bakelen, N B; Dijkstra, P U; Vissink, A; Bos, R R M; van Minnen, B

Published in:

International Journal of Oral and Maxillofacial Surgery DOI:

10.1016/j.ijom.2019.11.009

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Final author's version (accepted by publisher, after peer review)

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Gareb, B., van Bakelen, N. B., Dijkstra, P. U., Vissink, A., Bos, R. R. M., & van Minnen, B. (2020).

Biodegradable versus titanium osteosynthesis in maxillofacial traumatology: a systematic review with meta-analysis and trial sequential meta-analysis. International Journal of Oral and Maxillofacial Surgery, 49(7), 914-931. https://doi.org/10.1016/j.ijom.2019.11.009

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

RCT

Prosp. CS

Retrosp. CS

Random effects model

Random effects model

Random effects model

Heterogeneity: I2 = 0%, p = 0.89

Heterogeneity: I2 = 0%, p = 0.41 Test for effect in subgroup: p < 0.01

Test for effect in subgroup: p = 0.47

Bhatt et al. (2010) Ahmed et al. (2013) Gareb et al. (2017) Leonhardt et al. (2008) Leno et al. (2017) Wittwer et al. (2006) Park et al. (2011) Kang et al. (2014) Bhatt et al. (2015) Filinte et al. (2015) Kim et al. (2018) 0 0 0 5 2 3 3 0 0 0 0 60 51 197 18 34 8 30 21 39 56 53 24 12 13 5 4 3 4 0 2 0 5 5 1 3 58 50 167 13 35 10 30 20 15 26 56 36 19 15 0.11 1.51 0.39 0.07 0.11 0.18 1.25 4.77 0.58 3.28 0.10 0.14 0.52 0.16 [0.02; 0.57] [0.49; 4.65] [0.14; 1.11] [0.00; 1.10] [0.01; 2.04] [0.01; 2.97] [0.37; 4.21] [0.24; 93.44] [0.11; 3.12] [0.18; 61.30] [0.01; 1.69] [0.01; 2.34] [0.02; 11.79] [0.01; 2.90]

(3)

Study

Random effects model

Heterogeneity: I2 = 55%, p = 0.14 Test for overall effect: p = 0.58

Mahmoud et al. (2016) Leno et al. (2017) Total 37 14 23 Total 34 13 21 SMD -0.20 -0.61 0.13 95%-CI [-0.92; 0.52] [-1.39; 0.16] [-0.47; 0.72] -2 -1 0 1 2

Standardised Mean Difference

(4)

Retrosp. CS

Random effects model Tripathi et al. (2013) Kang et al. (2014) Filinte et al. (2015) Kim et al. (2018) 0 0 0 0 88 10 53 12 13 1 2 1 2 100 10 56 19 15 0.30 0.33 0.21 0.52 0.23 [0.07; 1.37] [0.02; 7.28] [0.01; 4.30] [0.02; 11.79] [0.01; 4.38]

(5)

Study

Test for subgroup differences: c02 = 0.00, df = 0 (p = NA) Retrosp. CS

Random effects model

Heterogeneity: I2 = 0%, p = 0.79 Test for effect in subgroup: p = 0.09

Bell et al. (2006) Wittwer et al. (2006) Kim et al. (2018) Events 1 3 1 Total 111 59 39 13 Events 0 0 0 Total 252 222 15 15 RR 4.55 11.22 2.75 3.44 95%-CI [0.78; 26.68] [0.46; 271.88] [0.15; 50.14] [0.15; 77.72] 0.01 0.1 0.5 1 2 10 100 Risk Ratio

(6)

Retrosp. CS

Random effects model

Heterogeneity: I2 = 0%, p = 0.52 Bell et al. (2006) Park et al. (2011) Kim et al. (2018) 1 1 1 128 59 56 13 0 0 1 263 222 26 15 2.37 11.22 1.41 1.15 [0.42; 13.23] [0.46; 271.88] [0.06; 33.40] [0.08; 16.67]

(7)

Study

Test for subgroup differences: c22 = 1.35, df = 2 (p = 0.51) RCT

Prosp. CS

Retrosp. CS

Random effects model

Random effects model

Random effects model

Heterogeneity: I2 = 0%, p = 0.83

Heterogeneity: I2 = 0%, p = 0.55

Heterogeneity: I2 = 0%, p = 0.96 Test for effect in subgroup: p = 0.22

Test for effect in subgroup: p = 0.49

Test for effect in subgroup: p = 0.82

Bhatt et al. (2010) Ahmed et al. (2013) Leonhardt et al. (2008) Qiu et al. (2015) Leno et al. (2017) Bell et al. (2006) Wittwer et al. (2006) Lee et al. (2010) Lim et al. (2014) Kang et al. (2014) Burlini et al. (2015) Filinte et al. (2015) Kim et al. (2018) Events 0 0 1 1 1 1 3 2 1 0 5 0 1 Total 51 98 447 17 34 30 45 23 59 39 48 13 53 210 12 13 Events 1 2 3 2 0 7 0 1 1 1 23 2 1 Total 52 96 1298 17 35 30 45 21 222 15 43 16 56 912 19 15 RR 0.26 0.60 0.92 0.33 0.21 0.33 0.50 2.74 0.54 2.75 1.79 1.23 0.35 0.94 0.31 1.15 95%-CI [0.03; 2.26] [0.14; 2.52] [0.46; 1.83] [0.01; 7.63] [0.01; 4.13] [0.04; 3.03] [0.05; 5.32] [0.12; 63.84] [0.07; 4.28] [0.15; 50.14] [0.17; 19.07] [0.08; 17.83] [0.01; 8.45] [0.36; 2.45] [0.02; 5.97] [0.08; 16.67] 0.01 0.1 0.5 1 2 10 100 Risk Ratio

(8)

RCT

Random effects model Bhatt et al. (2010) Buijs et al. (2012) Ahmed et al. (2013) 2 0 1 60 18 8 34 1 2 0 57 13 9 35 1.01 1.44 0.22 3.09 [0.21; 4.81] [0.15; 14.29] [0.01; 4.03] [0.13; 73.21]

(9)

Study

Test for subgroup differences: c02 = 0.00, df = 0 (p = NA) Retrosp. CS

Random effects model

Heterogeneity: I2 = 0%, p = 0.98 Test for effect in subgroup: p = 0.55

Bhatt et al. (2015) Filinte et al. (2015) Events 0 0 Total 36 24 12 Events 1 1 Total 55 36 19 RR 0.51 0.50 0.52 95%-CI [0.06; 4.68] [0.02; 11.70] [0.02; 11.79] 0.01 0.1 0.5 1 2 10 100 Risk Ratio

(10)

RCT

Random effects model Bhatt et al. (2010) Ahmed et al. (2013) 1 2 52 18 34 0 1 48 13 35 2.11 2.19 2.06 [0.32; 13.79] [0.10; 49.71] [0.20; 21.67]

(11)

Study

Test for subgroup differences: c02 = 0.00, df = 0 (p = NA) Retrosp. CS

Random effects model

Heterogeneity: I2 = 0%, p = 0.65 Test for effect in subgroup: p = 0.94

Bell et al. (2006) Filinte et al. (2015) Events 1 0 Total 71 59 12 Events 3 1 Total 241 222 19 RR 0.93 1.25 0.52 95%-CI [0.15; 5.75] [0.13; 11.84] [0.02; 11.79] 0.01 0.1 0.5 1 2 10 100 Risk Ratio

(12)

PubMed (n = 2257) EMBASE (n = 2269) CENTRAL (n = 475) Sc re en in g In cl u d e d El ig ib ili ty Id en ti fi ca ti o

n Reference lists, screening of

leading OMFS journals, and questioning experts for relevant

articles (n = 0)

Records after duplicates removed

(n = 3542)

Records screened by title and abstract

(n = 3542)

Records excluded

(n = 3462)

Full-text articles assessed for eligibility

(n = 80)

Full-text articles excluded

(n = 56)

- n = 47: did not fulfill inclusion criteria - n = 6 did fulfill exclusion criteria - n = 2 insufficient details - n = 1 included the same study population and endpoints with shorter follow-up

Studies included in qualitative synthesis

20 trauma and 4 trauma and orthognathic population(s)

(n = 24)

Studies included in the quantitative synthesis (meta-analysis)

(n = 21) EMBASE (n = 182)

CENTRAL (n = 132)

Excluded for quantitative synthesis (n = 3) - n = 1: single cost-effectiveness study - n = 1: total zero-event study - n = 1: included the same study population with shorter follow-up

Referenties

GERELATEERDE DOCUMENTEN

Biodegradable versus titanium osteosynthesis in maxillofacial traumatology: a systematic review with meta- analysis and trial sequential

35 Figure S9: Forest plot of the endpoint plate removal (overall follow-up) of studies including patients with mandibular fractures versus other fractures... 36 Figure S10:

- het snijpunt van deze raaklijn met het verlengde van BC noemen we R ; - we tekenen de omgeschreven cirkel.. van driehoek

dalam blotong untuk kampanje I96O naik untuk tjara kerdja sulfitasi asi apabila dibandingkan dengan kampanje 1959 (lihat tabel X l ) , wa- n&gt;o; io tebu dalam kampanje

Inclusion criteria were (1) study type: RCT (including cluster- randomized trial) and nonrandomized controlled study; (2) par- ticipants: humans with influenza (including

Verkerke, beste 3 e promotor, beste Bart, dank voor de samenwerking en de kritische commentaren ‘vanuit een andere invalshoek’ welke de 3 artikelen uit hoofdstuk 3

Een mogelijke verklaring is dat vanaf 1 miljoen jaar geleden het klimaat op aarde zó koud was dat gedurende een ijstijd de twee ijskap- pen die zich in Noord-Amerika vormden

Zo zijn we gestart met het maken van beleefboeken voor de beschermde afdeling van WZC Groenhof.. We zoeken een thema, bijvoorbeeld dieren, en zoeken mooie afbeeldingen